SME
IPO ·
BSE SME
Himalaya Nutravedics India Ltd
Listed
Hyderabad maker of Ayurvedic and nutraceutical products, also doing contract manufacturing.
Issue details
Price band
₹100 – ₹106
Face value
₹10
Lot size
1,200 shares
Minimum investment
₹2,54,400
Issue size
₹26.50 Cr
Fresh issue
₹26.50 Cr
Offer for sale
—
Issue type
Book Built
Exchange
BSE SME
Key dates
Opens
22 Sep 2026
Closes
24 Sep 2026
UPI mandate cut-off
5:00 PM on 24 Sep 2026
Allotment
25 Sep 2026
Refunds
28 Sep 2026
Shares in demat
28 Sep 2026
Listing
29 Sep 2026
Subscription and listing
Subscription
1.92x
Listing price
₹118
Registrar
KFin Technologies Ltd
Lead manager
Nirbhay Capital Services Pvt Ltd
Subscription by category
Total
1.92x
Total applications
1,014
Anchor investors
Amount raised
₹7.53 Cr
Bid date
21 Sep 2026
50% lock-in ends
24 Oct 2026
Rest lock-in ends
23 Dec 2026
Listing day
Issue price
₹106
Open
₹118.00
High
₹123.90
Low
₹118.00
Day close
₹122.90
Listing gain at open
+11.32%
Issue structure
Shares reserved per category and share of the total issue
QIB
11,84,400
47.38%
Anchor Investor
7,10,400
28.42%
QIB (Ex. Anchor)
4,74,000
18.96%
NII
3,56,400
14.26%
bNII > ₹10L
2,37,600
9.51%
sNII < ₹10L
1,18,800
4.75%
Retail
8,32,800
33.32%
Market Maker
1,26,000
5.04%
Total
24,99,600
100.00%
Finaccle’s quick read
Apply for long term
Income up 105% and PAT up 231% in FY26 with ROE of 63.87%, D/E of 0.31 and post-issue P/E of 12.63, but growth comes off a very small base in a company incorporated in 2022.
A rules-based screen of growth, margins, debt and valuation, built from the offer document and data on Chittorgarh.com. It is for information only and is not investment advice or a recommendation to buy or sell. Read the RHP and speak to a SEBI-registered adviser before you apply.
About the company
Himalaya Nutravedics makes and sells Ayurvedic and nutraceutical products from an integrated plant in Hyderabad, Telangana, and also does contract manufacturing for other brands. Its own brands made up about half of revenue in FY26, with products covering gut health, diabetes, cardiac, pain, immunity and women's wellness. It has 86 full-time staff and reported total income of ₹43.12 Cr in FY26.
Founded
Promoters
Products and segments
Promoter holding
Financial performance
Period
PAT
ROE
63.87%
ROCE
36.41%
Debt / equity
0.31
PAT margin
17.16%
P/E post issue
12.63
Market cap
₹93.35 Cr
Use of IPO money
Working capital requirements
₹13.75 Cr
Business development and digital marketing
₹7.50 Cr
General corporate purposes
₹3.17 Cr
Issue expenses
₹2.08 Cr
Strengths
✓
Integrated multi-dosage plant with WHO-GMP and AYUSH approvals
✓
Revenue doubled in FY26 with 17% PAT margin
✓
Low debt with debt/equity of 0.31
✓
Wide therapeutic range across wellness categories
✓
Entirely fresh issue
Risks to watch
!
Very young company, incorporated only in 2022
!
PAT rose 231% in FY26 from a small base
!
Small revenue base of ₹43 Cr
!
About half of revenue from lower-margin contract manufacturing
!
Crowded Ayurveda and nutraceutical market
Planning to take your own company public?
Every listing on this page started with a growing business that got its numbers, governance and paperwork ready for investors. If you are a promoter weighing an SME or main board IPO, we can tell you where you stand and what it will take.
Talk to our IPO Advisory team for readiness planning, or our IPO Consultancy team to run the listing end to end.
Last updated:
Information is compiled from exchange notices and the company’s offer document. It is for general information only and is not investment advice or a recommendation to apply. Read the prospectus before investing.